Revolution Medicines Inc is a clinical-stage precision oncology company dedicated to developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with a particular focus on the RAS and mTOR signaling pathways. The company's products include RMC-4630, an SHP2 inhibitor, the RAS (ON) product portfolio, as well as the SOS1 and 4EBP1/mTORC1 programs.

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for RVMD via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.